ConductScience.org, home

Paper16200070

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.

Harrington LE and 6 others. Nat Immunol, 2005. Cited by 3,683 papers, by iCite.

Cite this record

ConductScience Library. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Papers, record 16200070. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16200070

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.
PubMed
Journal
Nat Immunol
PubMed
Year
2005
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
3,683
iCite
Relative citation ratio, by iCite
77.6
iCite
Revised in PubMed
2025-01-03
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Harrington LELaurie E
2Hatton RDRobin D
3Mangan PRPaul R
4Turner HHenrietta
5Murphy TLTheresa L
6Murphy KMKenneth M
7Weaver CTCasey T

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Interleukin-17Major topic
T-Lymphocytes, Helper-InducerMajor topic
Th1 CellsMajor topic
Th2 CellsMajor topic
Transcription FactorsMajor topic
Animals
CD4 Antigens
Cell Lineage
DNA-Binding Proteins
Interferon Type I
Interferon-gamma
Interleukin-23
Interleukin-23 Subunit p19
Interleukins
Mice
Mice, Mutant Strains
STAT1 Transcription Factor
STAT4 Transcription Factor
STAT6 Transcription Factor
T-Box Domain Proteins
Trans-Activators
T-bet Transcription Factor

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
T32 AI007051NIAID NIH HHSUnited StatesT32AI007051PubMed and NIHNIH RePORTER
AI035783NIAID NIH HHSUnited StatesR01AI035783PubMed and NIHNIH RePORTER
AI057956NIAID NIH HHSUnited StatesR01AI057956PubMed and NIHNIH RePORTER
DK64400NIDDK NIH HHSUnited StatesR24DK064400PubMed and NIHNIH RePORTER
R21AI035783NIHNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in16239919T(H)-17: a giant step from T(H)1 and T(H)2.https://conductscience.org/library/papers/16239919

Source PubMed

Download CSV of comments and corrections

Cited by2,101

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3,683 citations.

PMIDTitleJournalYearIn PapersSource
42983836Th17 cells and neutrophils: exploiting their crosstalk for multiple sclerosis therapeutics.J Neuroinflammation2026https://conductscience.org/library/papers/42983836PubMed
42903518Twenty years of Th17: A dialogue on immunological innovation and translation.Hlife2026https://conductscience.org/library/papers/42903518PubMed
42840471Osteoimmunology: interactions of the bone and immune system.Front Immunol2026https://conductscience.org/library/papers/42840471PubMed
42830944Elevated IgE Levels in Psoriasis: An Atypical Subtype with Th2 Dominance and Overlapping Features of Atopic Dermatitis.Clin Cosmet Investig Dermatol2026https://conductscience.org/library/papers/42830944PubMed
42816471Targeting the HPGDS-PGD2 axis to treat Th17 cell-mediated autoimmunity in multiple sclerosis.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42816471PubMed
42741167Cytokine signatures associated with persistent antibody responses to multiple Plasmodium vivax blood-stage antigens.Front Immunol2026https://conductscience.org/library/papers/42741167PubMed
42712072T Cell Thoughts.Immunol Rev2026https://conductscience.org/library/papers/42712072PubMed
42711600Climate Change-Mediated Temperature Extremes: Effects on the Immune System and Associations with Immune-Related Diseases.Clin Rev Allergy Immunol2026https://conductscience.org/library/papers/42711600PubMed
42668492Immunopathogenesis of itch: an integrative framework for chronic pruritus.JID Innov2026https://conductscience.org/library/papers/42668492PubMed
42645185Potential Roles of Cellular Senescence and Inflammaging in Prostate Cancer: Aging Microenvironment, Immune Remodeling, and Therapeutic Implications.Cells2026https://conductscience.org/library/papers/42645185PubMed
42616895Unconventional role of hydroxymethylglutaryl-CoA synthase 1 in driving pathogenic TH17 cell immunity and autoimmune diseases.Sci Adv2026https://conductscience.org/library/papers/42616895PubMed
42592454Neutralizing dentin sialophosphoprotein facilitates tumor vascular normalization in colorectal cancer by blocking the crosstalk between tumor cells and endothelial cells.Acta Pharm Sin B2026https://conductscience.org/library/papers/42592454PubMed
42471730Decoding dry eye disease based on bioinformatics and in vitro experimental: the role of immune responses and natural product intervention.Hum Genomics2026https://conductscience.org/library/papers/42471730PubMed
42454030Fueling bone loss: the immunometabolic reprogramming of the bone microenvironment in diabetic osteoporosis.Front Immunol2026https://conductscience.org/library/papers/42454030PubMed
42440430Interleukin-10 at the crossroads of immunity in TLR7-induced lupus.Front Immunol2026https://conductscience.org/library/papers/42440430PubMed
42396441Multiple sclerosis and the limits of classical autoimmune theory.Front Immunol2026https://conductscience.org/library/papers/42396441PubMed
42351867
Artificial Intelligence-Driven Construction of Predictive and Druggable Frameworks to an In Silico Bioengineering Evidence Support for Therapy of Esophageal Squamous Cell Carcinoma Patients: Insights from a Toll-like Receptor Signal with Th17 and T Helper Microenvironment.
Bioengineering (Basel)2026https://conductscience.org/library/papers/42351867PubMed
42291469Vunakizumab for IL-17A-Mediated Diseases: A Review in Psoriasis and Spondyloarthritis.Biologics2026https://conductscience.org/library/papers/42291469PubMed
42286765The dual balance of the cytokine network: key messengers of immune activation and triggers of cytokine storm.Biomark Res2026https://conductscience.org/library/papers/42286765PubMed
42226175GGT-triggered self-immolative dexamethasone-oligopeptide prodrug nanoparticles ameliorate hepatic fibrosis via dual anti-inflammatory/immunomodulatory pathways with minimized systemic toxicity.J Nanobiotechnology2026https://conductscience.org/library/papers/42226175PubMed

See all 2,101 cited byDownload CSV of cited by

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16200070

GET https://conductscience.org/api/papers/v1/16200070/cited_by?page=2